193 related articles for article (PubMed ID: 38429927)
1. Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose.
Blaszkiewicz M; Tao T; Mensah-Arhin K; Willows JW; Bates R; Huang W; Cao L; Smith RL; Townsend KL
Mol Ther; 2024 May; 32(5):1407-1424. PubMed ID: 38429927
[TBL] [Abstract][Full Text] [Related]
2. Adipose Tissue Myeloid-Lineage Neuroimmune Cells Express Genes Important for Neural Plasticity and Regulate Adipose Innervation.
Blaszkiewicz M; Gunsch G; Willows JW; Gardner ML; Sepeda JA; Sas AR; Townsend KL
Front Endocrinol (Lausanne); 2022; 13():864925. PubMed ID: 35795142
[TBL] [Abstract][Full Text] [Related]
3. Neuropathy and neural plasticity in the subcutaneous white adipose depot.
Blaszkiewicz M; Willows JW; Dubois AL; Waible S; DiBello K; Lyons LL; Johnson CP; Paradie E; Banks N; Motyl K; Michael M; Harrison B; Townsend KL
PLoS One; 2019; 14(9):e0221766. PubMed ID: 31509546
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential.
Ding XW; Li R; Geetha T; Tao YX; Babu JR
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165858. PubMed ID: 32531260
[TBL] [Abstract][Full Text] [Related]
6. The involvement of neuroimmune cells in adipose innervation.
Blaszkiewicz M; Wood E; Koizar S; Willows J; Anderson R; Tseng YH; Godwin J; Townsend KL
Mol Med; 2020 Dec; 26(1):126. PubMed ID: 33297933
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.
Meloni M; Descamps B; Caporali A; Zentilin L; Floris I; Giacca M; Emanueli C
Diabetes; 2012 Jan; 61(1):229-40. PubMed ID: 22187379
[TBL] [Abstract][Full Text] [Related]
8. Selective regulation of nerve growth factor expression in developing cutaneous tissue by early sensory innervation.
Wyatt SL; Spori B; Vizard TN; Davies AM
Neural Dev; 2011 Apr; 6():18. PubMed ID: 21529369
[TBL] [Abstract][Full Text] [Related]
9. Expression of NGF, BDNF and their receptors in subcutaneous adipose tissue of lactating cows.
Colitti M; Loor JJ; Stefanon B
Res Vet Sci; 2015 Oct; 102():196-9. PubMed ID: 26412543
[TBL] [Abstract][Full Text] [Related]
10. AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.
Leake PA; Rebscher SJ; Dore' C; Akil O
J Assoc Res Otolaryngol; 2019 Aug; 20(4):341-361. PubMed ID: 31222416
[TBL] [Abstract][Full Text] [Related]
11. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.
Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
Gene Ther; 2006 Sep; 13(18):1328-41. PubMed ID: 16708079
[TBL] [Abstract][Full Text] [Related]
12. Low brain-derived neurotrophic factor protein levels and single-nucleotide polymorphism Val66Met are associated with peripheral neuropathy in type II diabetic patients.
Azoulay D; Abed S; Sfadi A; Sheleg O; Shaoul E; Shehadeh M; Kaykov E; Nodelman M; Bashkin A
Acta Diabetol; 2020 Jul; 57(7):891-898. PubMed ID: 32124075
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived nerve growth factor and brain-derived neurotrophic factor: results from experimental stress and diabetes.
Sornelli F; Fiore M; Chaldakov GN; Aloe L
Gen Physiol Biophys; 2009; 28 Spec No():179-83. PubMed ID: 19893098
[TBL] [Abstract][Full Text] [Related]
14. rAAV-Mediated Gene Delivery to Adipose Tissue.
Huang W; Queen NJ; Cao L
Methods Mol Biol; 2019; 1950():389-405. PubMed ID: 30783987
[TBL] [Abstract][Full Text] [Related]
15. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.
Dang Z; Avolio E; Albertario A; Sala-Newby GB; Thomas AC; Wang N; Emanueli C; Madeddu P
Diabetologia; 2019 Jul; 62(7):1297-1311. PubMed ID: 31016359
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
[TBL] [Abstract][Full Text] [Related]
18. Targeting adipose tissue via systemic gene therapy.
O'Neill SM; Hinkle C; Chen SJ; Sandhu A; Hovhannisyan R; Stephan S; Lagor WR; Ahima RS; Johnston JC; Reilly MP
Gene Ther; 2014 Jul; 21(7):653-61. PubMed ID: 24830434
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of human placental neurotrophic factors in preterm and term deliveries.
Dhobale MV; Pisal HR; Mehendale SS; Joshi SR
Int J Dev Neurosci; 2013 Dec; 31(8):719-23. PubMed ID: 24076518
[TBL] [Abstract][Full Text] [Related]
20. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils.
Shirakura M; Inoue M; Fujikawa S; Washizawa K; Komaba S; Maeda M; Watabe K; Yoshikawa Y; Hasegawa M
Gene Ther; 2004 May; 11(9):784-90. PubMed ID: 14961067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
